Skip to main content

The Globe and Mail

Bayer to buy software developer Radimetrics

An employee of German chemical and pharmaceutical maker Bayer controls processing equipment at the pill plant in Bitterfeld, eastern Germany, in this file picture.

ECKEHARD SCHULZ/AP

Drug multinational Bayer AG says it has struck a deal to buy Canadian healthcare software developer Radimetrics Inc.

Subsidiary Bayer HealthCare said Monday the principals of privately held Radimetrics have agreed to sell of their shares in the company.

Radimetrics' key product is eXposure, software that accurately measures a patient's radiation dose exposure over the course of multiple imaging procedures or scans.

Story continues below advertisement

Bayer HealthCare said eXposure also serves as a quality control and improvement platform.

Financial details of the agreement were not disclosed.

"This is a strategic acquisition as Bayer moves its Radiology & Interventional business forward to be the end-to-end provider of products, solutions and service for the radiology customer," Alan Main, head of Bayer HealthCare's medical care unit, said in a news release.

Radimetrics staff in Toronto and Scotland will be folded into Bayer, expanding Bayer's existing informatics group.

Radimetrics was founded in 2009.

Mr. Main said Bayer HealthCare's Radiology & Interventional group is poised as a market leader to help boost sales of eXposure.

Radimetrics president and founder Gregory Couch said the deal is "a new chapter in a great alliance which began earlier this year."

Story continues below advertisement

Report an error Licensing Options
About the Author
Quebec Business Correspondent

Bertrand has been covering Quebec business and finance since 2000. Before joining The Globe and Mail in 2000, he was the Toronto-based national business correspondent for Southam News. He has a B.A. from McGill University and a Bachelor of Applied Arts from Ryerson. More

Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Please note that our commenting partner Civil Comments is closing down. As such we will be implementing a new commenting partner in the coming weeks. As of December 20th, 2017 we will be shutting down commenting on all article pages across our site while we do the maintenance and updates. We understand that commenting is important to our audience and hope to have a technical solution in place January 2018.

Discussion loading… ✨